Page last updated: 2024-09-03

omega-n-methylarginine and Acute Coronary Syndrome

omega-n-methylarginine has been researched along with Acute Coronary Syndrome in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Béchir, M; Chenevard, R; Corti, R; Enseleit, F; Flammer, AJ; Hermann, M; Hürlimann, D; Lüscher, TF; Noll, G; Ruschitzka, F; Spieker, L; Sudano, I1

Trials

1 trial(s) available for omega-n-methylarginine and Acute Coronary Syndrome

ArticleYear
Reconstituted HDL in acute coronary syndromes.
    Cardiovascular therapeutics, 2012, Volume: 30, Issue:2

    Topics: Acetylcholine; Acute Coronary Syndrome; Aged; Biomarkers; Double-Blind Method; Electrocardiography; Endothelium, Vascular; Enzyme Inhibitors; Female; Fibrinolytic Agents; Hemodynamics; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipids; Lipoproteins, HDL; Male; Middle Aged; Nitroprusside; omega-N-Methylarginine; Oxidative Stress; Plethysmography; Vasculitis; Vasodilator Agents

2012